The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.

@article{Sullivan2004TheEI,
  title={The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines.},
  author={Patrick W. Sullivan and Michael B. Nichol},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2004},
  volume={7 4},
  pages={402-12}
}
OBJECTIVE As a result of the over-the-counter (OTC) introduction of loratadine, health plans have been struggling to determine the best policy to incorporate this change within their existing drug benefit structure for second-generation antihistamines (SGA). The objective of this study was to examine the economic impact of payer policies in response to the Rx-to-OTC switch of loratadine. STUDY DESIGN Decision analysis was used to model the budgetary impact and cost-effectiveness of four… CONTINUE READING

From This Paper

Topics from this paper.

Similar Papers

Loading similar papers…